Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).
Sven LöffelerHelena BertilssonChristoph MüllerKirsti AasHege Sagstuen HaugnesBjørg AksnessætherMaiju PesonenKristian ThonTorgrim TandstadTeemu MurtolaMads Hvid PoulsenTobias NordströmMaria Nyre VigmostadFredrik OttossonKarin HolmstenOla ChristiansenMarit SlaaenErik Skaaheim HaugAnne Holck StoråsLars AsphaugAntti Sakari RannikkoKlaus Brassonull nullPublished in: BJU international (2024)
Ethics approval has been granted in Norway (457593), Denmark (H-22051998), Finland (R23043) and Sweden (Dnr 2023-05296-01). The trial is registered on Clinicaltrials.org (NCT05448547).